Sign In
Buy NSTG
$0.105
+0 (+0%)
At Close: Dec 16, 2024
NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments
06:00am, Tuesday, 12'th Oct 2021
SEATTLE--(BUSINESS WIRE)--NanoString announces the launch of the nCounter® ADC Development Panel.
NanoString to Release Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021
06:00am, Wednesday, 06'th Oct 2021
SEATTLE--(BUSINESS WIRE)--NanoString to host third quarter 2021 operating results webcast on Tuesday, November 9th, 2021.
NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference
04:00pm, Wednesday, 01'st Sep 2021
SEATTLE--(BUSINESS WIRE)--NanoString to present at Morgan Stanley Global Healthcare Conference.
SEATTLE--(BUSINESS WIRE)--NanoString announced a peer-reviewed publication using the GeoMx® Digital Spatial Profiler (DSP), published in the journal Cell.
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript
09:51pm, Wednesday, 04'th Aug 2021
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q2 2021 Results - Earnings Call Transcript
NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021
06:00am, Thursday, 08'th Jul 2021
SEATTLE--(BUSINESS WIRE)--NanoString to report second quarter 2021 operating results and host conference call on Wednesday, August 4th.
NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy
06:00am, Tuesday, 22'nd Jun 2021
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter®
NanoString: Compelling Upside For This Spatial Biology Instrument Developer
12:15pm, Thursday, 17'th Jun 2021
NanoString Technologies, Inc. is a genomics/proteomics-focused developer of advanced instruments and consumables for scientific and clinical research. NanoString's products consist of two commercially
NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer
06:00am, Tuesday, 15'th Jun 2021
SEATTLE & SAN FRANCISCO--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and the Parker Institute for
NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference
06:00am, Thursday, 27'th May 2021
SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the Jefferies Virtual Healthcare conference.
Down More Than 20%, Is This Cathie Wood Biotech A Buy?
06:50am, Thursday, 20'th May 2021
10x Genomics stock has fallen, despite announcing strong first-quarter numbers.
NanoString to Webcast Presentation from the UBS Global Healthcare Conference
06:00am, Thursday, 20'th May 2021
SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the UBS Global Healthcare Conference.
NanoString's GeoMx Mouse Whole Transcriptome Atlas Expands Leadership in Spatial Genomics by Enabling Genome-Wide RNA Profiling
06:00am, Monday, 17'th May 2021
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability o
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2021 Results - Earnings Call Transcript
04:53pm, Tuesday, 11'th May 2021
NanoString Technologies, Inc. (NSTG) CEO Brad Gray on Q1 2021 Results - Earnings Call Transcript
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
06:02pm, Monday, 10'th May 2021
NanoString (NSTG) delivered earnings and revenue surprises of -6.90% and 5.19%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
